Thomas Meek

Looking forward to #EPAconf 2023 in Amsterdam later this month. Very interesting time for drug pricing and access! https://t.co/zoG6G7aFur

RT @podeuropa: So that’s it - the @EU_Health proposals on new #Pharmaceutical rules have now slipped from March 14 to March 29 on the @EU_C…

I'll be attending @CAR_TCell Europe conference in London next week. Looking like a busy couple of days https://t.co/Ttztbgs3eF

RT @apmhealtheurope: Industry response to @NICEComms's plans for updating its evaluation processes has been broadly positive. Read more on…

RT @apmhealtheurope: "We think the biggest drivers of change [in drug pricing] over the next decade will be employers", says @icer_review's…

RT @journ_jobs: APM Health Europe (@apmhealtheurope, ein englischsprachiger Nachrichtendienst, der über die Gesundheitspolitik und die phar…

RT @helenemauduit: I am #hiring - @apmhealtheurope is looking for a #Berlin-based journalist, fluent in German and English, to write on #he…

RT @apmhealtheurope: A senior Labour MP has called the UK government's plans to undermine the Northern Ireland protocol, including the pote…

UK government suggests "the simplest way forward may be to remove all medicines from the scope" of the N Ireland protocol due to supply/access issues. Read more: https://t.co/H4FCPIROoY #brexit #NIProtocol #pharma

EU 'ready to discuss' how U.S. proposal to waive IP protections for Covid-19 vaccines could address pandemic, says EC president Ursula von der Leyen (@vonderleyen ). Read more: https://t.co/6DAI3gi3Mv #pharma #vaccines #WaiveThePatents #covid19

RT @apmhealtheurope: "We are hearing a lot of suggestions that they want to tax #pharma companies... but the proceeds will just fall in the…

RT @apmhealtheurope: EU regulators recommend J&J's Covid vaccine carry blood clot warning similar to AstraZeneca's Vaxzevria. Read more: h…

RT @apmhealtheurope: EU regulators now investigating link between J&J's Covid vaccine and blood clot. Read more: https://t.co/PY0BqFHde0…

RT @apmhealtheurope: Experts have advised they have not been able to identify risk factors for link between AZN's Covid vaccine and serious…

RT @apmhealtheurope: How is the UK @MHRAgovuk's new reliance route for drug approvals? We spoke to Seagen's EVP, commercial international t…

RT @apmhealtheurope: EMA's safety committee is recommending label of AZN's Covid vaccine be updated to include risk on possible link to rar…

EMA's safety committee PRAC has come to "clear and scientific conclusion that this is a safe and effective vaccine" after review of risk of blood clots in AstraZeneca vaccine, says executive director Emer Cooke in ongoing press conference.